Prognostic benefit of selective portal vein occlusion during hepatic resection for hepatocellular carcinoma
Prognostic benefit of selective portal vein occlusion during hepatic resection for hepatocellular carcinoma
复制标题
DOI：
10.1016/j.surg.2005.02.008
复制
发表时间：
2005-06-01
期刊：
影响因子：
3.8
通讯作者：
Kai, M
中科院分区：
文献类型：
--
作者：
Makino, I;Chijiiwa, K;Kai, M
背景本研究的目的是阐明肝切除术中门静脉阻断的类型是否影响肝癌患者的长期预后。86名患者接受了。根据门静脉阻断的类型将肝癌根治性切除术分为2组：门静脉完全阻断组（TPVO，n = 56）和选择性门静脉阻断组（SPVO，n = 30）。比较两组间的无复发生存率，并通过单因素分析和多因素分析来检查影响无复发生存率的因素。同时，从两组中抽取直径小于5cm的单发结节性HCC患者，比较无复发生存率。
Background. The aim of this study was to clarify whether the types of portal vein (PV) occlusion during hepatectomy affect the long-term outcome in patients with hepatocellular carcinoma (HCC).Methods. Eighty-six patients who had undergone. curative hepatic resection for HCC were divided on the basis of the type of PV occlusion into 2 groups: total PV occlusion (TPVO, n = 56) and selective PV occlusion (SPVO, n = 30) groups. The recurrence-free survival was compared between the groups, and factors affecting recurrence-free survival were examined by univariate analyses followed by multivariate analyses. Moreover, the patients with a single nodular HCC less than 5 cm in diameter were abstracted from both groups, and the recurrence free survival rate was compared.